Overview
Artios secured £87 million in a Series D funding round led by SV Health Investors, RA Capital Management, and Janus Henderson Investors. Founded in 2016, the Cambridge-based health tech company focuses on targeting DNA damage response in cancer treatment.
Products
Loading...
Recent Deals
Investors: SV Health Investors, RA Capital Management, Janus Henderson Investors
Artios secured £87 million in a Series D funding round led by SV Health Investors, RA Capital Management, and Janus Henderson Investors. Founded in 2016, the Cambridge-based health tech company focuses on targeting DNA damage response in cancer treatment.